EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022

Kimberly H Nguyen iD, Yingjun Bao, Julie Mortazavi, Jennifer D Allen iD, Patricia O Chocano-Bedoya, Laura Corlin iD

Vaccines · 18.01.2024 · 12 (1) · 99

DOI: 10.3390/vaccines12010099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 18.01.2024. Verfasst von Kimberly H Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA 30322, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tufts University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long COVID and its symptoms have not been examined in different subpopulations of U.S. adults. Using the 2022 BRFSS (n = 445,132), we assessed long COVID and each symptom by sociodemographic characteristics and health-related variables. Multivariable logistic regression was conducted to examine factors associated with long COVID and the individual symptoms. Prevalence differences were conducted to examine differences in long COVID by vaccination status. Overall, more than one in five adults who ever had COVID-19 reported symptoms consistent with long COVID (21.8%). The most common symptom was tiredness or fatigue (26.2%), followed by difficulty breathing or shortness of breath (18.9%), and loss of taste or smell (17.0%). Long COVID was more common among adults under 65 years, women, American Indian or Alaska Native or other/multi race group, smokers, and people with a disability, depression, overweight or obesity compared to their respective counterparts. The prevalence of long COVID was higher among unvaccinated adults (25.6%) than vaccinated adults (21.6%) overall, and for 20 of 32 subgroups assessed. These findings underscore the benefits of vaccination, the importance of early treatment, and the need to better inform health care resource allocation and support services for those experiencing long COVID.

Schlagwörter

Stichwörter der Autor:innen

COVID-19 outcomesCOVID-19 vaccinationadultsdisparitieslong COVIDsymptomsvaccine confidencevaccine hesitancy

Autor:innen und Institutionen

  • Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA 30322, USA.
  • Department of Epidemiology, George Washington University Milken School of Public Health, Washington, DC 20037, USA.
  • Department of Public Health & Community Medicine, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Department of Community Health, Tufts School of Arts and Sciences, Medford, MA 02115, USA.
  • Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland.
  • Department of Civil and Environmental Engineering, Tufts University School of Engineering, Medford, MA 02155, USA.

ORCID-Profile: Kimberly H Nguyen, Jennifer D Allen, Laura Corlin

Förderung

  • Tufts University

Zitieren

APA

Nguyen, K. H., Bao, Y., Mortazavi, J., Allen, J. D., Chocano-Bedoya, P. O., & Corlin, L. (2024). Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022. Vaccines, 12(1), 99. https://doi.org/10.3390/vaccines12010099

Vancouver

Nguyen KH, Bao Y, Mortazavi J, Allen JD, Chocano-Bedoya PO, Corlin L. Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022. Vaccines. 2024;12(1):99. doi:10.3390/vaccines12010099

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Kimberly H and Bao, Yingjun and Mortazavi, Julie and Allen, Jennifer D and Chocano-Bedoya, Patricia O and Corlin, Laura},
  title = {Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022},
  journal = {Vaccines},
  year = {2024},
  volume = {12},
  number = {1},
  pages = {99},
  doi = {10.3390/vaccines12010099}
}
Kostenlos starten →